2015-2025 Global Rare Disease Drug Market Research by Type, End-Use and Region (COVID-19)
SUMMARY
The global Rare Disease Drug market is expected to reach xxx Million USD by 2025, with a CAGR of xx% from 2020 to 2025.
Further key aspects of the report indicate that:
Key Companies
The global Rare Disease Drug market is expected to reach xxx Million USD by 2025, with a CAGR of xx% from 2020 to 2025.
Further key aspects of the report indicate that:
- Chapter 1: Market Definition and Segment by Type, End-Use & Major Regions Market Size
- Chapter 2: Global Production & Consumption Market by Type and End-Use
- Chapter 3: Europe Production & Consumption Market by Type and End-Use
- Chapter 4: America Production & Consumption Market by Type and End-Use
- Chapter 5: Asia Production & Consumption Market by Type and End-Use
- Chapter 6: Oceania Production & Consumption Market by Type and End-Use
- Chapter 7: Africa Production & Consumption Market by Type and End-Use
- Chapter 8: Global Market Forecast by Type, End-Use and Region
- Chapter 9: Company information, Sales, Cost, Margin, news etc.
- Chapter 10: Market Competition by Companies and Market Concentration Ratio
- Chapter 11: Market Impact by Coronavirus.
- Chapter 12: Industry Summary
Key Companies
- Novartis AG
- Bristol-Myers Squibb Company
- Celgene Corporation
- F. Hoffmann-La Roche Ltd.
- Pfizer, Inc.
- Sanofi S.A.
- Alexion Pharmaceuticals, Inc.
- Eli Lilly and Company
- Novo Nordisk A/S
- AstraZeneca
- Eisai Co., Ltd.
- Daiichi Sankyo Company Limited
- Bayer AG
- GlaxoSmithKline
- Merck & Co., Inc.
- Johnson & Johnson
- Biogen, Inc.
- Shire
- Amgen, Inc.
- Deciphera
- Atara Biotherapeutics
- ProQR
- >1
- 0.65 1
- <0.1
- Hospital Pharmacies
- Speciality Pharmacies
- Retail pharmacies
- Others
CHAPTER 1 MARKET OVERVIEW
1.1 Market Definition and Segment
1.1.1 Product Definition
1.1.2 Product Type
1.1.3 End-Use
1.1.4 Marketing Channel
1.2 Major Regions
1.2.1 Europe Market Size and Growth
Figure Europe Rare Disease Drug Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure Europe Rare Disease Drug Market Forecast and Growth Rate, 2020E-2025F (Million USD)
1.2.2 America Market Size and Growth
Figure America Rare Disease Drug Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure America Rare Disease Drug Market Forecast and Growth Rate, 2020E-2025F (Million USD)
1.2.3 Asia Market Size and Growth
Figure Asia Rare Disease Drug Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure AsiaRare Disease Drug Market Forecast and Growth Rate, 2020E-2025F (Million USD)
1.2.4 Oceania Market Size and Growth
Figure Oceania Rare Disease Drug Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure Oceania Rare Disease Drug Market Forecast and Growth Rate, 2020E-2025F (Million USD)
1.2.5 Africa Market Size and Growth
Figure Africa Rare Disease Drug Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure Africa Rare Disease Drug Market Forecast and Growth Rate, 2020E-2025F (Million USD)
CHAPTER 2 GLOBAL MARKET SEGMENTATION
2.1 Global Production Overview
Table Global Rare Disease Drug Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
2.2 Global Consumption Overview
Table Global Rare Disease Drug Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
2.3 Global Production by Type
Table Global Rare Disease Drug Revenue by Type, 2015-2020 (Million USD)
Figure Global Rare Disease Drug Revenue Share by Type in 2020 (Million USD)
Table Global Rare Disease Drug Production Volume by Type, 2015-2020 (Volume)
Figure Global Rare Disease Drug Production Volume Share by Type in 2020 (Volume)
2.4 Global Consumption by End-Use
Table Global Rare Disease Drug Consumption Value by End-Use, 2015-2020 (Million USD)
Figure Global Rare Disease Drug Consumption Value Share by End-Use in 2020 (Million USD)
Table Global Rare Disease Drug Consumption Volume by End-Use, 2015-2020 (Volume)
Figure Global Rare Disease Drug Consumption Volume Share by End-Use in 2020 (Volume)
2.5 Global Consumption by Region
Table Global Rare Disease Drug Consumption Value by Region, 2015-2020 (Million USD)
Table Global Rare Disease Drug Consumption Volume by Region, 2015-2020 (Volume)
CHAPTER 3 EUROPE MARKET SEGMENTATION
3.1 Europe Production Overview
Table Europe Rare Disease Drug Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
3.2 Europe Consumption Overview
Table Europe Rare Disease Drug Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
3.3 Europe Production by Type
Table Europe Rare Disease Drug Revenue by Type, 2015-2020 (Million USD)
Figure Europe Rare Disease Drug Revenue Share by Type in 2020 (Million USD)
Table Europe Rare Disease Drug Production Volume by Type, 2015-2020 (Volume)
Figure Europe Rare Disease Drug Production Volume Share by Type in 2020 (Volume)
3.4 Europe Consumption by End-Use
Table Europe Rare Disease Drug Consumption Value by End-Use, 2015-2020 (Million USD)
Figure Europe Rare Disease Drug Consumption Value Share by End-Use in 2020 (Million USD)
Table Europe Rare Disease Drug Consumption Volume by End-Use, 2015-2020 (Volume)
Figure Europe Rare Disease Drug Consumption Volume Share by End-Use in 2020 (Volume)
3.5 Europe Consumption by Region
Table Europe Rare Disease Drug Consumption Value by Region, 2015-2020 (Million USD)
Table Europe Rare Disease Drug Consumption Volume by Region, 2015-2020 (Volume)
CHAPTER 4 AMERICA MARKET SEGMENTATION
4.1 America Production Overview
Table America Rare Disease Drug Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
4.2 America Consumption Overview
Table America Rare Disease Drug Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
4.3 America Production by Type
Table America Rare Disease Drug Revenue by Type, 2015-2020 (Million USD)
Figure America Rare Disease Drug Revenue Share by Type in 2020 (Million USD)
Table America Rare Disease Drug Production Volume by Type, 2015-2020 (Volume)
Figure America Rare Disease Drug Production Volume Share by Type in 2020 (Volume)
4.4 America Consumption by End-Use
Table America Rare Disease Drug Consumption Value by End-Use, 2015-2020 (Million USD)
Figure America Rare Disease Drug Consumption Value Share by End-Use in 2020 (Million USD)
Table America Rare Disease Drug Consumption Volume by End-Use, 2015-2020 (Volume)
Figure America Rare Disease Drug Consumption Volume Share by End-Use in 2020 (Volume)
4.5 America Consumption by Region
Table America Rare Disease Drug Consumption Value by Region, 2015-2020 (Million USD)
Table America Rare Disease Drug Consumption Volume by Region, 2015-2020 (Volume)
CHAPTER 5 ASIA MARKET SEGMENTATION
5.1 Asia Production Overview
Table Asia Rare Disease Drug Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
5.2 Asia Consumption Overview
Table Asia Rare Disease Drug Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
5.3 Asia Production by Type
Table Asia Rare Disease Drug Revenue by Type, 2015-2020 (Million USD)
Figure Asia Rare Disease Drug Revenue Share by Type in 2020 (Million USD)
Table Asia Rare Disease Drug Production Volume by Type, 2015-2020 (Volume)
Figure Asia Rare Disease Drug Production Volume Share by Type in 2020 (Volume)
5.4 Asia Consumption by End-Use
Table Asia Rare Disease Drug Consumption Value by End-Use, 2015-2020 (Million USD)
Figure Asia Rare Disease Drug Consumption Value Share by End-Use in 2020 (Million USD)
Table Asia Rare Disease Drug Consumption Volume by End-Use, 2015-2020 (Volume)
Figure Asia Rare Disease Drug Consumption Volume Share by End-Use in 2020 (Volume)
5.5 Asia Consumption by Region
Table Asia Rare Disease Drug Consumption Value by Region, 2015-2020 (Million USD)
Table Asia Rare Disease Drug Consumption Volume by Region, 2015-2020 (Volume)
CHAPTER 6 OCEANIA MARKET SEGMENTATION
6.1 Oceania Production Overview
Table Oceania Rare Disease Drug Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
6.2 Oceania Consumption Overview
Table Oceania Rare Disease Drug Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
6.3 Oceania Production by Type
Table Oceania Rare Disease Drug Revenue by Type, 2015-2020 (Million USD)
Figure Oceania Rare Disease Drug Revenue Share by Type in 2020 (Million USD)
Table Oceania Rare Disease Drug Production Volume by Type, 2015-2020 (Volume)
Figure Oceania Rare Disease Drug Production Volume Share by Type in 2020 (Volume)
6.4 Oceania Consumption by End-Use
Table Oceania Rare Disease Drug Consumption Value by End-Use, 2015-2020 (Million USD)
Figure Oceania Rare Disease Drug Consumption Value Share by End-Use in 2020 (Million USD)
Table Oceania Rare Disease Drug Consumption Volume by End-Use, 2015-2020 (Volume)
Figure Oceania Rare Disease Drug Consumption Volume Share by End-Use in 2020 (Volume)
6.5 Oceania Consumption by Region
Table Oceania Rare Disease Drug Consumption Value by Region, 2015-2020 (Million USD)
Table Oceania Rare Disease Drug Consumption Volume by Region, 2015-2020 (Volume)
CHAPTER 7 AFRICA MARKET SEGMENTATION
7.1 Africa Production Overview
Table Africa Rare Disease Drug Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
7.2 Africa Consumption Overview
Table Africa Rare Disease Drug Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
7.3 Africa Production by Type
Table Africa Rare Disease Drug Revenue by Type, 2015-2020 (Million USD)
Figure Africa Rare Disease Drug Revenue Share by Type in 2020 (Million USD)
Table Africa Rare Disease Drug Production Volume by Type, 2015-2020 (Volume)
Figure Africa Rare Disease Drug Production Volume Share by Type in 2020 (Volume)
7.4 Africa Consumption by End-Use
Table Africa Rare Disease Drug Consumption Value by End-Use, 2015-2020 (Million USD)
Figure Africa Rare Disease Drug Consumption Value Share by End-Use in 2020 (Million USD)
Table Africa Rare Disease Drug Consumption Volume by End-Use, 2015-2020 (Volume)
Figure Africa Rare Disease Drug Consumption Volume Share by End-Use in 2020 (Volume)
7.5 Africa Consumption by Region
Table Africa Rare Disease Drug Consumption Value by Region, 2015-2020 (Million USD)
Table Africa Rare Disease Drug Consumption Volume by Region, 2015-2020 (Volume)
CHAPTER 8 GLOBAL MARKET FORECAST
8.1 Global Rare Disease Drug Production Forecast
Figure Global Rare Disease Drug Revenue and Growth Rate Forecast 2020E-2025F (Million USD)
Figure Global Rare Disease Drug Production Volume and Growth Rate Forecast 2020E-2025F (Volume)
8.2 Global Rare Disease Drug Forecast by Type
Table Global Rare Disease Drug Revenue by Type, 2020E-2025F (Million USD)
Figure Global Rare Disease Drug Revenue Share by Type in 2025 (Million USD)
Table Global Rare Disease Drug Production Volume by Type, 2020E-2025F (Volume)
Figure Global Rare Disease Drug Production Volume Share by Type in 2025 (Volume)
8.3 Global Rare Disease Drug Forecast by End-Use (2020E-2025F)
Table Global Rare Disease Drug Consumption Value by End-Use, 2020E-2025F (Million USD)
Figure Global Rare Disease Drug Consumption Value Share by End-Use in 2025 (Million USD)
Table Global Rare Disease Drug Consumption Volume by End-Use, 2020E-2025F (Volume)
8.4 Global Rare Disease Drug Forecast by Region (2020E-2025F)
Table Global Rare Disease Drug Consumption Value by Region, 2020E-2025F (Million USD)
Figure Global Rare Disease Drug Consumption Value Share by Region in 2025 (Million USD)
Table Global Rare Disease Drug Consumption Volume by Region, 2020E-2025F (Volume)
Figure Global Rare Disease Drug Consumption Volume Share by Region in 2025 (Volume)
CHAPTER 9 GLOBAL MAJOR COMPANIES LIST
9.1 Novartis AG
9.1.1 Novartis AG Profile
Table Novartis AG Overview List
9.1.2 Novartis AG Products & Services
9.1.3 Novartis AG Company Dynamics & News
9.1.4 Novartis AG Business Operation Conditions
Table Business Operation of Novartis AG (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.2 Bristol-Myers Squibb Company
9.2.1 Bristol-Myers Squibb Company Profile
Table Bristol-Myers Squibb Company Overview List
9.2.2 Bristol-Myers Squibb Company Products & Services
9.2.3 Bristol-Myers Squibb Company Company Dynamics & News
9.2.4 Bristol-Myers Squibb Company Business Operation Conditions
Table Business Operation of Bristol-Myers Squibb Company (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.3 Celgene Corporation
9.3.1 Celgene Corporation Profile
Table Celgene Corporation Overview List
9.3.2 Celgene Corporation Products & Services
9.3.3 Celgene Corporation Company Dynamics & News
9.3.4 Celgene Corporation Business Operation Conditions
Table Business Operation of Celgene Corporation (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.4 F. Hoffmann-La Roche Ltd.
9.4.1 F. Hoffmann-La Roche Ltd. Profile
Table F. Hoffmann-La Roche Ltd. Overview List
9.4.2 F. Hoffmann-La Roche Ltd. Products & Services
9.4.3 F. Hoffmann-La Roche Ltd. Company Dynamics & News
9.4.4 F. Hoffmann-La Roche Ltd. Business Operation Conditions
Table Business Operation of F. Hoffmann-La Roche Ltd. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.5 Pfizer, Inc.
9.5.1 Pfizer, Inc. Profile
Table Pfizer, Inc. Overview List
9.5.2 Pfizer, Inc. Products & Services
9.5.3 Pfizer, Inc. Company Dynamics & News
9.5.4 Pfizer, Inc. Business Operation Conditions
Table Business Operation of Pfizer, Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.6 Sanofi S.A.
9.6.1 Sanofi S.A. Profile
Table Sanofi S.A. Overview List
9.6.2 Sanofi S.A. Products & Services
9.6.3 Sanofi S.A. Company Dynamics & News
9.6.4 Sanofi S.A. Business Operation Conditions
Table Business Operation of Sanofi S.A. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.7 Alexion Pharmaceuticals, Inc.
9.7.1 Alexion Pharmaceuticals, Inc. Profile
Table Alexion Pharmaceuticals, Inc. Overview List
9.7.2 Alexion Pharmaceuticals, Inc. Products & Services
9.7.3 Alexion Pharmaceuticals, Inc. Company Dynamics & News
9.7.4 Alexion Pharmaceuticals, Inc. Business Operation Conditions
Table Business Operation of Alexion Pharmaceuticals, Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.8 Eli Lilly and Company
9.8.1 Eli Lilly and Company Profile
Table Eli Lilly and Company Overview List
9.8.2 Eli Lilly and Company Products & Services
9.8.3 Eli Lilly and Company Company Dynamics & News
9.8.4 Eli Lilly and Company Business Operation Conditions
Table Business Operation of Eli Lilly and Company (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.9 Novo Nordisk A/S
9.9.1 Novo Nordisk A/S Profile
Table Novo Nordisk A/S Overview List
9.9.2 Novo Nordisk A/S Products & Services
9.9.3 Novo Nordisk A/S Company Dynamics & News
9.9.4 Novo Nordisk A/S Business Operation Conditions
Table Business Operation of Novo Nordisk A/S (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.10 AstraZeneca
9.10.1 AstraZeneca Profile
Table AstraZeneca Overview List
9.10.2 AstraZeneca Products & Services
9.10.3 AstraZeneca Company Dynamics & News
9.10.4 AstraZeneca Business Operation Conditions
Table Business Operation of AstraZeneca (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.11 Eisai Co., Ltd.
9.11.1 Eisai Co., Ltd. Profile
Table Eisai Co., Ltd. Overview List
9.11.2 Eisai Co., Ltd. Products & Services
9.11.3 Eisai Co., Ltd. Company Dynamics & News
9.11.4 Eisai Co., Ltd. Business Operation Conditions
Table Business Operation of Eisai Co., Ltd. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.12 Daiichi Sankyo Company Limited
9.12.1 Daiichi Sankyo Company Limited Profile
Table Daiichi Sankyo Company Limited Overview List
9.12.2 Daiichi Sankyo Company Limited Products & Services
9.12.3 Daiichi Sankyo Company Limited Company Dynamics & News
9.12.4 Daiichi Sankyo Company Limited Business Operation Conditions
Table Business Operation of Daiichi Sankyo Company Limited (Sales Revenue, Cost, Gross Margin)
9.13 Bayer AG
9.13.1 Bayer AG Profile
Table Bayer AG Overview List
9.13.2 Bayer AG Products & Services
9.13.3 Bayer AG Company Dynamics & News
9.13.4 Bayer AG Business Operation Conditions
Table Business Operation of Bayer AG (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.14 GlaxoSmithKline
9.14.1 GlaxoSmithKline Profile
Table GlaxoSmithKline Overview List
9.14.2 GlaxoSmithKline Products & Services
9.14.3 GlaxoSmithKline Company Dynamics & News
9.14.4 GlaxoSmithKline Business Operation Conditions
Table Business Operation of GlaxoSmithKline (Sales Revenue, Cost, Gross Margin)
9.15 Merck & Co., Inc.
9.15.1 Merck & Co., Inc. Profile
Table Merck & Co., Inc. Overview List
9.15.2 Merck & Co., Inc. Products & Services
9.15.3 Merck & Co., Inc. Company Dynamics & News
9.15.4 Merck & Co., Inc. Business Operation Conditions
Table Business Operation of Merck & Co., Inc. (Sales Revenue, Cost, Gross Margin)
9.16 Johnson & Johnson
9.16.1 Johnson & Johnson Profile
Table Johnson & Johnson Overview List
9.16.2 Johnson & Johnson Products & Services
9.16.3 Johnson & Johnson Company Dynamics & News
9.16.4 Johnson & Johnson Business Operation Conditions
Table Business Operation of Johnson & Johnson (Sales Revenue, Cost, Gross Margin)
9.17 Biogen, Inc.
9.17.1 Biogen, Inc. Profile
Table Biogen, Inc. Overview List
9.17.2 Biogen, Inc. Products & Services
9.17.3 Biogen, Inc. Company Dynamics & News
9.17.4 Biogen, Inc. Business Operation Conditions
Table Business Operation of Biogen, Inc. (Sales Revenue, Cost, Gross Margin)
9.18 Shire
9.18.1 Shire Profile
Table Shire Overview List
9.18.2 Shire Products & Services
9.18.3 Shire Company Dynamics & News
9.18.4 Shire Business Operation Conditions
Table Business Operation of Shire (Sales Revenue, Cost, Gross Margin)
9.19 Amgen, Inc.
9.19.1 Amgen, Inc. Profile
Table Amgen, Inc. Overview List
9.19.2 Amgen, Inc. Products & Services
9.19.3 Amgen, Inc. Company Dynamics & News
9.19.4 Amgen, Inc. Business Operation Conditions
Table Business Operation of Amgen, Inc. (Sales Revenue, Cost, Gross Margin)
9.20 Deciphera
9.20.1 Deciphera Profile
Table Deciphera Overview List
9.20.2 Deciphera Products & Services
9.20.3 Deciphera Company Dynamics & News
9.20.4 Deciphera Business Operation Conditions
Table Business Operation of Deciphera (Sales Revenue, Cost, Gross Margin)
9.21 Atara Biotherapeutics
9.21.1 Atara Biotherapeutics Profile
Table Atara Biotherapeutics Overview List
9.21.2 Atara Biotherapeutics Products & Services
9.21.3 Atara Biotherapeutics Company Dynamics & News
9.21.4 Atara Biotherapeutics Business Operation Conditions
Table Business Operation of Atara Biotherapeutics (Sales Revenue, Cost, Gross Margin)
9.22 ProQR
9.22.1 ProQR Profile
Table ProQR Overview List
9.22.2 ProQR Products & Services
9.22.4 ProQR Business Operation Conditions
Table Business Operation of ProQR (Sales Revenue, Cost, Gross Margin)
PART 10 MARKET COMPETITION
10.1 Key Company Market Share
Table Global Rare Disease Drug Sales Revenue 2015-2020E, by Companies, in USD Million
Table Global Rare Disease Drug Sales Revenue Share, 2015-2020E, by Companies, in USD
Table Global Rare Disease Drug Sales Volume by Companies, 2015-2020E (Volume)
Table Global Rare Disease Drug Sales Volume Share by Companies, 2015-2020E (Volume)
10.2 Regional Market Concentration
Figure Europe Rare Disease Drug Market Concentration Ratio in 2020E
Figure America Rare Disease Drug Market Concentration Ratio in 2020E
Figure Asia Rare Disease Drug Market Concentration Ratio in 2020E
Figure Oceania Rare Disease Drug Market Concentration Ratio in 2020E
Figure Africa Rare Disease Drug Market Concentration Ratio in 2020E
PART 11 CORONAVIRUS IMPACT ON RARE DISEASE DRUG INDUSTRY
11.1 Impact on Industry Upstream
11.2 Impact on Industry Downstream
11.3 Impact on Industry Channels
11.4 Impact on Industry Competition
11.5 Impact on Industry Obtain Employment
PART 12 RARE DISEASE DRUG INDUSTRY SUMMARY & CONCLUSION
1.1 Market Definition and Segment
1.1.1 Product Definition
1.1.2 Product Type
1.1.3 End-Use
1.1.4 Marketing Channel
1.2 Major Regions
1.2.1 Europe Market Size and Growth
Figure Europe Rare Disease Drug Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure Europe Rare Disease Drug Market Forecast and Growth Rate, 2020E-2025F (Million USD)
1.2.2 America Market Size and Growth
Figure America Rare Disease Drug Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure America Rare Disease Drug Market Forecast and Growth Rate, 2020E-2025F (Million USD)
1.2.3 Asia Market Size and Growth
Figure Asia Rare Disease Drug Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure AsiaRare Disease Drug Market Forecast and Growth Rate, 2020E-2025F (Million USD)
1.2.4 Oceania Market Size and Growth
Figure Oceania Rare Disease Drug Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure Oceania Rare Disease Drug Market Forecast and Growth Rate, 2020E-2025F (Million USD)
1.2.5 Africa Market Size and Growth
Figure Africa Rare Disease Drug Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure Africa Rare Disease Drug Market Forecast and Growth Rate, 2020E-2025F (Million USD)
CHAPTER 2 GLOBAL MARKET SEGMENTATION
2.1 Global Production Overview
Table Global Rare Disease Drug Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
2.2 Global Consumption Overview
Table Global Rare Disease Drug Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
2.3 Global Production by Type
Table Global Rare Disease Drug Revenue by Type, 2015-2020 (Million USD)
Figure Global Rare Disease Drug Revenue Share by Type in 2020 (Million USD)
Table Global Rare Disease Drug Production Volume by Type, 2015-2020 (Volume)
Figure Global Rare Disease Drug Production Volume Share by Type in 2020 (Volume)
2.4 Global Consumption by End-Use
Table Global Rare Disease Drug Consumption Value by End-Use, 2015-2020 (Million USD)
Figure Global Rare Disease Drug Consumption Value Share by End-Use in 2020 (Million USD)
Table Global Rare Disease Drug Consumption Volume by End-Use, 2015-2020 (Volume)
Figure Global Rare Disease Drug Consumption Volume Share by End-Use in 2020 (Volume)
2.5 Global Consumption by Region
Table Global Rare Disease Drug Consumption Value by Region, 2015-2020 (Million USD)
Table Global Rare Disease Drug Consumption Volume by Region, 2015-2020 (Volume)
CHAPTER 3 EUROPE MARKET SEGMENTATION
3.1 Europe Production Overview
Table Europe Rare Disease Drug Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
3.2 Europe Consumption Overview
Table Europe Rare Disease Drug Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
3.3 Europe Production by Type
Table Europe Rare Disease Drug Revenue by Type, 2015-2020 (Million USD)
Figure Europe Rare Disease Drug Revenue Share by Type in 2020 (Million USD)
Table Europe Rare Disease Drug Production Volume by Type, 2015-2020 (Volume)
Figure Europe Rare Disease Drug Production Volume Share by Type in 2020 (Volume)
3.4 Europe Consumption by End-Use
Table Europe Rare Disease Drug Consumption Value by End-Use, 2015-2020 (Million USD)
Figure Europe Rare Disease Drug Consumption Value Share by End-Use in 2020 (Million USD)
Table Europe Rare Disease Drug Consumption Volume by End-Use, 2015-2020 (Volume)
Figure Europe Rare Disease Drug Consumption Volume Share by End-Use in 2020 (Volume)
3.5 Europe Consumption by Region
Table Europe Rare Disease Drug Consumption Value by Region, 2015-2020 (Million USD)
Table Europe Rare Disease Drug Consumption Volume by Region, 2015-2020 (Volume)
CHAPTER 4 AMERICA MARKET SEGMENTATION
4.1 America Production Overview
Table America Rare Disease Drug Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
4.2 America Consumption Overview
Table America Rare Disease Drug Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
4.3 America Production by Type
Table America Rare Disease Drug Revenue by Type, 2015-2020 (Million USD)
Figure America Rare Disease Drug Revenue Share by Type in 2020 (Million USD)
Table America Rare Disease Drug Production Volume by Type, 2015-2020 (Volume)
Figure America Rare Disease Drug Production Volume Share by Type in 2020 (Volume)
4.4 America Consumption by End-Use
Table America Rare Disease Drug Consumption Value by End-Use, 2015-2020 (Million USD)
Figure America Rare Disease Drug Consumption Value Share by End-Use in 2020 (Million USD)
Table America Rare Disease Drug Consumption Volume by End-Use, 2015-2020 (Volume)
Figure America Rare Disease Drug Consumption Volume Share by End-Use in 2020 (Volume)
4.5 America Consumption by Region
Table America Rare Disease Drug Consumption Value by Region, 2015-2020 (Million USD)
Table America Rare Disease Drug Consumption Volume by Region, 2015-2020 (Volume)
CHAPTER 5 ASIA MARKET SEGMENTATION
5.1 Asia Production Overview
Table Asia Rare Disease Drug Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
5.2 Asia Consumption Overview
Table Asia Rare Disease Drug Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
5.3 Asia Production by Type
Table Asia Rare Disease Drug Revenue by Type, 2015-2020 (Million USD)
Figure Asia Rare Disease Drug Revenue Share by Type in 2020 (Million USD)
Table Asia Rare Disease Drug Production Volume by Type, 2015-2020 (Volume)
Figure Asia Rare Disease Drug Production Volume Share by Type in 2020 (Volume)
5.4 Asia Consumption by End-Use
Table Asia Rare Disease Drug Consumption Value by End-Use, 2015-2020 (Million USD)
Figure Asia Rare Disease Drug Consumption Value Share by End-Use in 2020 (Million USD)
Table Asia Rare Disease Drug Consumption Volume by End-Use, 2015-2020 (Volume)
Figure Asia Rare Disease Drug Consumption Volume Share by End-Use in 2020 (Volume)
5.5 Asia Consumption by Region
Table Asia Rare Disease Drug Consumption Value by Region, 2015-2020 (Million USD)
Table Asia Rare Disease Drug Consumption Volume by Region, 2015-2020 (Volume)
CHAPTER 6 OCEANIA MARKET SEGMENTATION
6.1 Oceania Production Overview
Table Oceania Rare Disease Drug Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
6.2 Oceania Consumption Overview
Table Oceania Rare Disease Drug Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
6.3 Oceania Production by Type
Table Oceania Rare Disease Drug Revenue by Type, 2015-2020 (Million USD)
Figure Oceania Rare Disease Drug Revenue Share by Type in 2020 (Million USD)
Table Oceania Rare Disease Drug Production Volume by Type, 2015-2020 (Volume)
Figure Oceania Rare Disease Drug Production Volume Share by Type in 2020 (Volume)
6.4 Oceania Consumption by End-Use
Table Oceania Rare Disease Drug Consumption Value by End-Use, 2015-2020 (Million USD)
Figure Oceania Rare Disease Drug Consumption Value Share by End-Use in 2020 (Million USD)
Table Oceania Rare Disease Drug Consumption Volume by End-Use, 2015-2020 (Volume)
Figure Oceania Rare Disease Drug Consumption Volume Share by End-Use in 2020 (Volume)
6.5 Oceania Consumption by Region
Table Oceania Rare Disease Drug Consumption Value by Region, 2015-2020 (Million USD)
Table Oceania Rare Disease Drug Consumption Volume by Region, 2015-2020 (Volume)
CHAPTER 7 AFRICA MARKET SEGMENTATION
7.1 Africa Production Overview
Table Africa Rare Disease Drug Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
7.2 Africa Consumption Overview
Table Africa Rare Disease Drug Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
7.3 Africa Production by Type
Table Africa Rare Disease Drug Revenue by Type, 2015-2020 (Million USD)
Figure Africa Rare Disease Drug Revenue Share by Type in 2020 (Million USD)
Table Africa Rare Disease Drug Production Volume by Type, 2015-2020 (Volume)
Figure Africa Rare Disease Drug Production Volume Share by Type in 2020 (Volume)
7.4 Africa Consumption by End-Use
Table Africa Rare Disease Drug Consumption Value by End-Use, 2015-2020 (Million USD)
Figure Africa Rare Disease Drug Consumption Value Share by End-Use in 2020 (Million USD)
Table Africa Rare Disease Drug Consumption Volume by End-Use, 2015-2020 (Volume)
Figure Africa Rare Disease Drug Consumption Volume Share by End-Use in 2020 (Volume)
7.5 Africa Consumption by Region
Table Africa Rare Disease Drug Consumption Value by Region, 2015-2020 (Million USD)
Table Africa Rare Disease Drug Consumption Volume by Region, 2015-2020 (Volume)
CHAPTER 8 GLOBAL MARKET FORECAST
8.1 Global Rare Disease Drug Production Forecast
Figure Global Rare Disease Drug Revenue and Growth Rate Forecast 2020E-2025F (Million USD)
Figure Global Rare Disease Drug Production Volume and Growth Rate Forecast 2020E-2025F (Volume)
8.2 Global Rare Disease Drug Forecast by Type
Table Global Rare Disease Drug Revenue by Type, 2020E-2025F (Million USD)
Figure Global Rare Disease Drug Revenue Share by Type in 2025 (Million USD)
Table Global Rare Disease Drug Production Volume by Type, 2020E-2025F (Volume)
Figure Global Rare Disease Drug Production Volume Share by Type in 2025 (Volume)
8.3 Global Rare Disease Drug Forecast by End-Use (2020E-2025F)
Table Global Rare Disease Drug Consumption Value by End-Use, 2020E-2025F (Million USD)
Figure Global Rare Disease Drug Consumption Value Share by End-Use in 2025 (Million USD)
Table Global Rare Disease Drug Consumption Volume by End-Use, 2020E-2025F (Volume)
8.4 Global Rare Disease Drug Forecast by Region (2020E-2025F)
Table Global Rare Disease Drug Consumption Value by Region, 2020E-2025F (Million USD)
Figure Global Rare Disease Drug Consumption Value Share by Region in 2025 (Million USD)
Table Global Rare Disease Drug Consumption Volume by Region, 2020E-2025F (Volume)
Figure Global Rare Disease Drug Consumption Volume Share by Region in 2025 (Volume)
CHAPTER 9 GLOBAL MAJOR COMPANIES LIST
9.1 Novartis AG
9.1.1 Novartis AG Profile
Table Novartis AG Overview List
9.1.2 Novartis AG Products & Services
9.1.3 Novartis AG Company Dynamics & News
9.1.4 Novartis AG Business Operation Conditions
Table Business Operation of Novartis AG (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.2 Bristol-Myers Squibb Company
9.2.1 Bristol-Myers Squibb Company Profile
Table Bristol-Myers Squibb Company Overview List
9.2.2 Bristol-Myers Squibb Company Products & Services
9.2.3 Bristol-Myers Squibb Company Company Dynamics & News
9.2.4 Bristol-Myers Squibb Company Business Operation Conditions
Table Business Operation of Bristol-Myers Squibb Company (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.3 Celgene Corporation
9.3.1 Celgene Corporation Profile
Table Celgene Corporation Overview List
9.3.2 Celgene Corporation Products & Services
9.3.3 Celgene Corporation Company Dynamics & News
9.3.4 Celgene Corporation Business Operation Conditions
Table Business Operation of Celgene Corporation (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.4 F. Hoffmann-La Roche Ltd.
9.4.1 F. Hoffmann-La Roche Ltd. Profile
Table F. Hoffmann-La Roche Ltd. Overview List
9.4.2 F. Hoffmann-La Roche Ltd. Products & Services
9.4.3 F. Hoffmann-La Roche Ltd. Company Dynamics & News
9.4.4 F. Hoffmann-La Roche Ltd. Business Operation Conditions
Table Business Operation of F. Hoffmann-La Roche Ltd. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.5 Pfizer, Inc.
9.5.1 Pfizer, Inc. Profile
Table Pfizer, Inc. Overview List
9.5.2 Pfizer, Inc. Products & Services
9.5.3 Pfizer, Inc. Company Dynamics & News
9.5.4 Pfizer, Inc. Business Operation Conditions
Table Business Operation of Pfizer, Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.6 Sanofi S.A.
9.6.1 Sanofi S.A. Profile
Table Sanofi S.A. Overview List
9.6.2 Sanofi S.A. Products & Services
9.6.3 Sanofi S.A. Company Dynamics & News
9.6.4 Sanofi S.A. Business Operation Conditions
Table Business Operation of Sanofi S.A. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.7 Alexion Pharmaceuticals, Inc.
9.7.1 Alexion Pharmaceuticals, Inc. Profile
Table Alexion Pharmaceuticals, Inc. Overview List
9.7.2 Alexion Pharmaceuticals, Inc. Products & Services
9.7.3 Alexion Pharmaceuticals, Inc. Company Dynamics & News
9.7.4 Alexion Pharmaceuticals, Inc. Business Operation Conditions
Table Business Operation of Alexion Pharmaceuticals, Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.8 Eli Lilly and Company
9.8.1 Eli Lilly and Company Profile
Table Eli Lilly and Company Overview List
9.8.2 Eli Lilly and Company Products & Services
9.8.3 Eli Lilly and Company Company Dynamics & News
9.8.4 Eli Lilly and Company Business Operation Conditions
Table Business Operation of Eli Lilly and Company (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.9 Novo Nordisk A/S
9.9.1 Novo Nordisk A/S Profile
Table Novo Nordisk A/S Overview List
9.9.2 Novo Nordisk A/S Products & Services
9.9.3 Novo Nordisk A/S Company Dynamics & News
9.9.4 Novo Nordisk A/S Business Operation Conditions
Table Business Operation of Novo Nordisk A/S (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.10 AstraZeneca
9.10.1 AstraZeneca Profile
Table AstraZeneca Overview List
9.10.2 AstraZeneca Products & Services
9.10.3 AstraZeneca Company Dynamics & News
9.10.4 AstraZeneca Business Operation Conditions
Table Business Operation of AstraZeneca (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.11 Eisai Co., Ltd.
9.11.1 Eisai Co., Ltd. Profile
Table Eisai Co., Ltd. Overview List
9.11.2 Eisai Co., Ltd. Products & Services
9.11.3 Eisai Co., Ltd. Company Dynamics & News
9.11.4 Eisai Co., Ltd. Business Operation Conditions
Table Business Operation of Eisai Co., Ltd. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.12 Daiichi Sankyo Company Limited
9.12.1 Daiichi Sankyo Company Limited Profile
Table Daiichi Sankyo Company Limited Overview List
9.12.2 Daiichi Sankyo Company Limited Products & Services
9.12.3 Daiichi Sankyo Company Limited Company Dynamics & News
9.12.4 Daiichi Sankyo Company Limited Business Operation Conditions
Table Business Operation of Daiichi Sankyo Company Limited (Sales Revenue, Cost, Gross Margin)
9.13 Bayer AG
9.13.1 Bayer AG Profile
Table Bayer AG Overview List
9.13.2 Bayer AG Products & Services
9.13.3 Bayer AG Company Dynamics & News
9.13.4 Bayer AG Business Operation Conditions
Table Business Operation of Bayer AG (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.14 GlaxoSmithKline
9.14.1 GlaxoSmithKline Profile
Table GlaxoSmithKline Overview List
9.14.2 GlaxoSmithKline Products & Services
9.14.3 GlaxoSmithKline Company Dynamics & News
9.14.4 GlaxoSmithKline Business Operation Conditions
Table Business Operation of GlaxoSmithKline (Sales Revenue, Cost, Gross Margin)
9.15 Merck & Co., Inc.
9.15.1 Merck & Co., Inc. Profile
Table Merck & Co., Inc. Overview List
9.15.2 Merck & Co., Inc. Products & Services
9.15.3 Merck & Co., Inc. Company Dynamics & News
9.15.4 Merck & Co., Inc. Business Operation Conditions
Table Business Operation of Merck & Co., Inc. (Sales Revenue, Cost, Gross Margin)
9.16 Johnson & Johnson
9.16.1 Johnson & Johnson Profile
Table Johnson & Johnson Overview List
9.16.2 Johnson & Johnson Products & Services
9.16.3 Johnson & Johnson Company Dynamics & News
9.16.4 Johnson & Johnson Business Operation Conditions
Table Business Operation of Johnson & Johnson (Sales Revenue, Cost, Gross Margin)
9.17 Biogen, Inc.
9.17.1 Biogen, Inc. Profile
Table Biogen, Inc. Overview List
9.17.2 Biogen, Inc. Products & Services
9.17.3 Biogen, Inc. Company Dynamics & News
9.17.4 Biogen, Inc. Business Operation Conditions
Table Business Operation of Biogen, Inc. (Sales Revenue, Cost, Gross Margin)
9.18 Shire
9.18.1 Shire Profile
Table Shire Overview List
9.18.2 Shire Products & Services
9.18.3 Shire Company Dynamics & News
9.18.4 Shire Business Operation Conditions
Table Business Operation of Shire (Sales Revenue, Cost, Gross Margin)
9.19 Amgen, Inc.
9.19.1 Amgen, Inc. Profile
Table Amgen, Inc. Overview List
9.19.2 Amgen, Inc. Products & Services
9.19.3 Amgen, Inc. Company Dynamics & News
9.19.4 Amgen, Inc. Business Operation Conditions
Table Business Operation of Amgen, Inc. (Sales Revenue, Cost, Gross Margin)
9.20 Deciphera
9.20.1 Deciphera Profile
Table Deciphera Overview List
9.20.2 Deciphera Products & Services
9.20.3 Deciphera Company Dynamics & News
9.20.4 Deciphera Business Operation Conditions
Table Business Operation of Deciphera (Sales Revenue, Cost, Gross Margin)
9.21 Atara Biotherapeutics
9.21.1 Atara Biotherapeutics Profile
Table Atara Biotherapeutics Overview List
9.21.2 Atara Biotherapeutics Products & Services
9.21.3 Atara Biotherapeutics Company Dynamics & News
9.21.4 Atara Biotherapeutics Business Operation Conditions
Table Business Operation of Atara Biotherapeutics (Sales Revenue, Cost, Gross Margin)
9.22 ProQR
9.22.1 ProQR Profile
Table ProQR Overview List
9.22.2 ProQR Products & Services
9.22.4 ProQR Business Operation Conditions
Table Business Operation of ProQR (Sales Revenue, Cost, Gross Margin)
PART 10 MARKET COMPETITION
10.1 Key Company Market Share
Table Global Rare Disease Drug Sales Revenue 2015-2020E, by Companies, in USD Million
Table Global Rare Disease Drug Sales Revenue Share, 2015-2020E, by Companies, in USD
Table Global Rare Disease Drug Sales Volume by Companies, 2015-2020E (Volume)
Table Global Rare Disease Drug Sales Volume Share by Companies, 2015-2020E (Volume)
10.2 Regional Market Concentration
Figure Europe Rare Disease Drug Market Concentration Ratio in 2020E
Figure America Rare Disease Drug Market Concentration Ratio in 2020E
Figure Asia Rare Disease Drug Market Concentration Ratio in 2020E
Figure Oceania Rare Disease Drug Market Concentration Ratio in 2020E
Figure Africa Rare Disease Drug Market Concentration Ratio in 2020E
PART 11 CORONAVIRUS IMPACT ON RARE DISEASE DRUG INDUSTRY
11.1 Impact on Industry Upstream
11.2 Impact on Industry Downstream
11.3 Impact on Industry Channels
11.4 Impact on Industry Competition
11.5 Impact on Industry Obtain Employment
PART 12 RARE DISEASE DRUG INDUSTRY SUMMARY & CONCLUSION
LIST OF TABLES
Table Global Rare Disease Drug Revenue by Type, 2015-2020 (Million USD)
Table Global Rare Disease Drug Production Volume by Type, 2015-2020 (Volume)
Table Global Rare Disease Drug Consumption Value by End-Use, 2015-2020 (Million USD)
Table Global Rare Disease Drug Consumption Volume by End-Use, 2015-2020 (Volume)
Table Global Rare Disease Drug Consumption Value by Region, 2015-2020 (Million USD)
Table Global Rare Disease Drug Consumption Volume by Region, 2015-2020 (Volume)
Table Europe Rare Disease Drug Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
Table Europe Rare Disease Drug Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
Table Europe Rare Disease Drug Revenue by Type, 2015-2020 (Million USD)
Table Europe Rare Disease Drug Production Volume by Type, 2015-2020 (Volume)
Table Europe Rare Disease Drug Consumption Value by End-Use, 2015-2020 (Million USD)
Table Europe Rare Disease Drug Consumption Volume by End-Use, 2015-2020 (Volume)
Table Europe Rare Disease Drug Consumption Value by Region, 2015-2020 (Million USD)
Table Europe Rare Disease Drug Consumption Volume by Region, 2015-2020 (Volume)
Table America Rare Disease Drug Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
Table America Rare Disease Drug Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
Table America Rare Disease Drug Revenue by Type, 2015-2020 (Million USD)
Table America Rare Disease Drug Production Volume by Type, 2015-2020 (Volume)
Table America Rare Disease Drug Consumption Value by End-Use, 2015-2020 (Million USD)
Table America Rare Disease Drug Consumption Volume by End-Use, 2015-2020 (Volume)
Table America Rare Disease Drug Consumption Value by Region, 2015-2020 (Million USD)
Table America Rare Disease Drug Consumption Volume by Region, 2015-2020 (Volume)
Table Asia Rare Disease Drug Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
Table Asia Rare Disease Drug Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
Table Asia Rare Disease Drug Revenue by Type, 2015-2020 (Million USD)
Table Asia Rare Disease Drug Production Volume by Type, 2015-2020 (Volume)
Table Asia Rare Disease Drug Consumption Value by End-Use, 2015-2020 (Million USD)
Table Asia Rare Disease Drug Consumption Volume by End-Use, 2015-2020 (Volume)
Table Asia Rare Disease Drug Consumption Value by Region, 2015-2020 (Million USD)
Table Asia Rare Disease Drug Consumption Volume by Region, 2015-2020 (Volume)
Table Oceania Rare Disease Drug Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
Table Oceania Rare Disease Drug Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
Table Oceania Rare Disease Drug Revenue by Type, 2015-2020 (Million USD)
Table Oceania Rare Disease Drug Production Volume by Type, 2015-2020 (Volume)
Table Oceania Rare Disease Drug Consumption Value by End-Use, 2015-2020 (Million USD)
Table Oceania Rare Disease Drug Consumption Volume by End-Use, 2015-2020 (Volume)
Table Oceania Rare Disease Drug Consumption Value by Region, 2015-2020 (Million USD)
Table Oceania Rare Disease Drug Consumption Volume by Region, 2015-2020 (Volume)
Table Africa Rare Disease Drug Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
Table Africa Rare Disease Drug Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
Table Africa Rare Disease Drug Revenue by Type, 2015-2020 (Million USD)
Table Africa Rare Disease Drug Production Volume by Type, 2015-2020 (Volume)
Table Africa Rare Disease Drug Consumption Value by End-Use, 2015-2020 (Million USD)
Table Africa Rare Disease Drug Consumption Volume by End-Use, 2015-2020 (Volume)
Table Africa Rare Disease Drug Consumption Value by Region, 2015-2020 (Million USD)
Table Africa Rare Disease Drug Consumption Volume by Region, 2015-2020 (Volume)
Table Global Rare Disease Drug Revenue by Type, 2020E-2025F (Million USD)
Table Global Rare Disease Drug Production Volume by Type, 2020E-2025F (Volume)
Table Global Rare Disease Drug Consumption Value by End-Use, 2020E-2025F (Million USD)
Table Global Rare Disease Drug Consumption Volume by End-Use, 2020E-2025F (Volume)
Table Global Rare Disease Drug Consumption Value by Region, 2020E-2025F (Million USD)
Table Global Rare Disease Drug Consumption Volume by Region, 2020E-2025F (Volume)
Table Novartis AG Overview List
Table Business Operation of Novartis AG (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Bristol-Myers Squibb Company Overview List
Table Business Operation of Bristol-Myers Squibb Company (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Celgene Corporation Overview List
Table Business Operation of Celgene Corporation (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table F. Hoffmann-La Roche Ltd. Overview List
Table Business Operation of F. Hoffmann-La Roche Ltd. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Pfizer, Inc. Overview List
Table Business Operation of Pfizer, Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Sanofi S.A. Overview List
Table Business Operation of Sanofi S.A. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Alexion Pharmaceuticals, Inc. Overview List
Table Business Operation of Alexion Pharmaceuticals, Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Eli Lilly and Company Overview List
Table Business Operation of Eli Lilly and Company (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Novo Nordisk A/S Overview List
Table Business Operation of Novo Nordisk A/S (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table AstraZeneca Overview List
Table Business Operation of AstraZeneca (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Eisai Co., Ltd. Overview List
Table Business Operation of Eisai Co., Ltd. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Daiichi Sankyo Company Limited Overview List
Table Business Operation of Daiichi Sankyo Company Limited (Sales Revenue, Cost, Gross Margin)
Table Bayer AG Overview List
Table Business Operation of Bayer AG (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table GlaxoSmithKline Overview List
Table Business Operation of GlaxoSmithKline (Sales Revenue, Cost, Gross Margin)
Table Merck & Co., Inc. Overview List
Table Business Operation of Merck & Co., Inc. (Sales Revenue, Cost, Gross Margin)
Table Johnson & Johnson Overview List
Table Business Operation of Johnson & Johnson (Sales Revenue, Cost, Gross Margin)
Table Biogen, Inc. Overview List
Table Business Operation of Biogen, Inc. (Sales Revenue, Cost, Gross Margin)
Table Shire Overview List
Table Business Operation of Shire (Sales Revenue, Cost, Gross Margin)
Table Amgen, Inc. Overview List
Table Business Operation of Amgen, Inc. (Sales Revenue, Cost, Gross Margin)
Table Deciphera Overview List
Table Business Operation of Deciphera (Sales Revenue, Cost, Gross Margin)
Table Atara Biotherapeutics Overview List
Table Business Operation of Atara Biotherapeutics (Sales Revenue, Cost, Gross Margin)
Table ProQR Overview List
Table Business Operation of ProQR (Sales Revenue, Cost, Gross Margin)
Table Global Rare Disease Drug Sales Revenue 2015-2020E, by Companies, in USD Million
Table Global Rare Disease Drug Sales Revenue Share, 2015-2020E, by Companies, in USD
Table Global Rare Disease Drug Sales Volume by Companies, 2015-2020E (Volume)
Table Global Rare Disease Drug Sales Volume Share by Companies, 2015-2020E (Volume)
Table Global Rare Disease Drug Revenue by Type, 2015-2020 (Million USD)
Table Global Rare Disease Drug Production Volume by Type, 2015-2020 (Volume)
Table Global Rare Disease Drug Consumption Value by End-Use, 2015-2020 (Million USD)
Table Global Rare Disease Drug Consumption Volume by End-Use, 2015-2020 (Volume)
Table Global Rare Disease Drug Consumption Value by Region, 2015-2020 (Million USD)
Table Global Rare Disease Drug Consumption Volume by Region, 2015-2020 (Volume)
Table Europe Rare Disease Drug Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
Table Europe Rare Disease Drug Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
Table Europe Rare Disease Drug Revenue by Type, 2015-2020 (Million USD)
Table Europe Rare Disease Drug Production Volume by Type, 2015-2020 (Volume)
Table Europe Rare Disease Drug Consumption Value by End-Use, 2015-2020 (Million USD)
Table Europe Rare Disease Drug Consumption Volume by End-Use, 2015-2020 (Volume)
Table Europe Rare Disease Drug Consumption Value by Region, 2015-2020 (Million USD)
Table Europe Rare Disease Drug Consumption Volume by Region, 2015-2020 (Volume)
Table America Rare Disease Drug Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
Table America Rare Disease Drug Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
Table America Rare Disease Drug Revenue by Type, 2015-2020 (Million USD)
Table America Rare Disease Drug Production Volume by Type, 2015-2020 (Volume)
Table America Rare Disease Drug Consumption Value by End-Use, 2015-2020 (Million USD)
Table America Rare Disease Drug Consumption Volume by End-Use, 2015-2020 (Volume)
Table America Rare Disease Drug Consumption Value by Region, 2015-2020 (Million USD)
Table America Rare Disease Drug Consumption Volume by Region, 2015-2020 (Volume)
Table Asia Rare Disease Drug Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
Table Asia Rare Disease Drug Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
Table Asia Rare Disease Drug Revenue by Type, 2015-2020 (Million USD)
Table Asia Rare Disease Drug Production Volume by Type, 2015-2020 (Volume)
Table Asia Rare Disease Drug Consumption Value by End-Use, 2015-2020 (Million USD)
Table Asia Rare Disease Drug Consumption Volume by End-Use, 2015-2020 (Volume)
Table Asia Rare Disease Drug Consumption Value by Region, 2015-2020 (Million USD)
Table Asia Rare Disease Drug Consumption Volume by Region, 2015-2020 (Volume)
Table Oceania Rare Disease Drug Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
Table Oceania Rare Disease Drug Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
Table Oceania Rare Disease Drug Revenue by Type, 2015-2020 (Million USD)
Table Oceania Rare Disease Drug Production Volume by Type, 2015-2020 (Volume)
Table Oceania Rare Disease Drug Consumption Value by End-Use, 2015-2020 (Million USD)
Table Oceania Rare Disease Drug Consumption Volume by End-Use, 2015-2020 (Volume)
Table Oceania Rare Disease Drug Consumption Value by Region, 2015-2020 (Million USD)
Table Oceania Rare Disease Drug Consumption Volume by Region, 2015-2020 (Volume)
Table Africa Rare Disease Drug Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
Table Africa Rare Disease Drug Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
Table Africa Rare Disease Drug Revenue by Type, 2015-2020 (Million USD)
Table Africa Rare Disease Drug Production Volume by Type, 2015-2020 (Volume)
Table Africa Rare Disease Drug Consumption Value by End-Use, 2015-2020 (Million USD)
Table Africa Rare Disease Drug Consumption Volume by End-Use, 2015-2020 (Volume)
Table Africa Rare Disease Drug Consumption Value by Region, 2015-2020 (Million USD)
Table Africa Rare Disease Drug Consumption Volume by Region, 2015-2020 (Volume)
Table Global Rare Disease Drug Revenue by Type, 2020E-2025F (Million USD)
Table Global Rare Disease Drug Production Volume by Type, 2020E-2025F (Volume)
Table Global Rare Disease Drug Consumption Value by End-Use, 2020E-2025F (Million USD)
Table Global Rare Disease Drug Consumption Volume by End-Use, 2020E-2025F (Volume)
Table Global Rare Disease Drug Consumption Value by Region, 2020E-2025F (Million USD)
Table Global Rare Disease Drug Consumption Volume by Region, 2020E-2025F (Volume)
Table Novartis AG Overview List
Table Business Operation of Novartis AG (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Bristol-Myers Squibb Company Overview List
Table Business Operation of Bristol-Myers Squibb Company (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Celgene Corporation Overview List
Table Business Operation of Celgene Corporation (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table F. Hoffmann-La Roche Ltd. Overview List
Table Business Operation of F. Hoffmann-La Roche Ltd. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Pfizer, Inc. Overview List
Table Business Operation of Pfizer, Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Sanofi S.A. Overview List
Table Business Operation of Sanofi S.A. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Alexion Pharmaceuticals, Inc. Overview List
Table Business Operation of Alexion Pharmaceuticals, Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Eli Lilly and Company Overview List
Table Business Operation of Eli Lilly and Company (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Novo Nordisk A/S Overview List
Table Business Operation of Novo Nordisk A/S (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table AstraZeneca Overview List
Table Business Operation of AstraZeneca (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Eisai Co., Ltd. Overview List
Table Business Operation of Eisai Co., Ltd. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Daiichi Sankyo Company Limited Overview List
Table Business Operation of Daiichi Sankyo Company Limited (Sales Revenue, Cost, Gross Margin)
Table Bayer AG Overview List
Table Business Operation of Bayer AG (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table GlaxoSmithKline Overview List
Table Business Operation of GlaxoSmithKline (Sales Revenue, Cost, Gross Margin)
Table Merck & Co., Inc. Overview List
Table Business Operation of Merck & Co., Inc. (Sales Revenue, Cost, Gross Margin)
Table Johnson & Johnson Overview List
Table Business Operation of Johnson & Johnson (Sales Revenue, Cost, Gross Margin)
Table Biogen, Inc. Overview List
Table Business Operation of Biogen, Inc. (Sales Revenue, Cost, Gross Margin)
Table Shire Overview List
Table Business Operation of Shire (Sales Revenue, Cost, Gross Margin)
Table Amgen, Inc. Overview List
Table Business Operation of Amgen, Inc. (Sales Revenue, Cost, Gross Margin)
Table Deciphera Overview List
Table Business Operation of Deciphera (Sales Revenue, Cost, Gross Margin)
Table Atara Biotherapeutics Overview List
Table Business Operation of Atara Biotherapeutics (Sales Revenue, Cost, Gross Margin)
Table ProQR Overview List
Table Business Operation of ProQR (Sales Revenue, Cost, Gross Margin)
Table Global Rare Disease Drug Sales Revenue 2015-2020E, by Companies, in USD Million
Table Global Rare Disease Drug Sales Revenue Share, 2015-2020E, by Companies, in USD
Table Global Rare Disease Drug Sales Volume by Companies, 2015-2020E (Volume)
Table Global Rare Disease Drug Sales Volume Share by Companies, 2015-2020E (Volume)
LIST OF FIGURES
Figure Europe Rare Disease Drug Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure Europe Rare Disease Drug Market Forecast and Growth Rate, 2020E-2025F (Million USD)
Figure America Rare Disease Drug Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure America Rare Disease Drug Market Forecast and Growth Rate, 2020E-2025F (Million USD)
Figure Asia Rare Disease Drug Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure AsiaRare Disease Drug Market Forecast and Growth Rate, 2020E-2025F (Million USD)
Figure Oceania Rare Disease Drug Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure Oceania Rare Disease Drug Market Forecast and Growth Rate, 2020E-2025F (Million USD)
Figure Africa Rare Disease Drug Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure Africa Rare Disease Drug Market Forecast and Growth Rate, 2020E-2025F (Million USD)
Figure Global Rare Disease Drug Revenue Share by Type in 2020 (Million USD)
Figure Global Rare Disease Drug Production Volume Share by Type in 2020 (Volume)
Figure Global Rare Disease Drug Consumption Value Share by End-Use in 2020 (Million USD)
Figure Global Rare Disease Drug Consumption Volume Share by End-Use in 2020 (Volume)
Figure Europe Rare Disease Drug Revenue Share by Type in 2020 (Million USD)
Figure Europe Rare Disease Drug Production Volume Share by Type in 2020 (Volume)
Figure Europe Rare Disease Drug Consumption Value Share by End-Use in 2020 (Million USD)
Figure Europe Rare Disease Drug Consumption Volume Share by End-Use in 2020 (Volume)
Figure America Rare Disease Drug Revenue Share by Type in 2020 (Million USD)
Figure America Rare Disease Drug Production Volume Share by Type in 2020 (Volume)
Figure America Rare Disease Drug Consumption Value Share by End-Use in 2020 (Million USD)
Figure America Rare Disease Drug Consumption Volume Share by End-Use in 2020 (Volume)
Figure Asia Rare Disease Drug Revenue Share by Type in 2020 (Million USD)
Figure Asia Rare Disease Drug Production Volume Share by Type in 2020 (Volume)
Figure Asia Rare Disease Drug Consumption Value Share by End-Use in 2020 (Million USD)
Figure Asia Rare Disease Drug Consumption Volume Share by End-Use in 2020 (Volume)
Figure Oceania Rare Disease Drug Revenue Share by Type in 2020 (Million USD)
Figure Oceania Rare Disease Drug Production Volume Share by Type in 2020 (Volume)
Figure Oceania Rare Disease Drug Consumption Value Share by End-Use in 2020 (Million USD)
Figure Oceania Rare Disease Drug Consumption Volume Share by End-Use in 2020 (Volume)
Figure Africa Rare Disease Drug Revenue Share by Type in 2020 (Million USD)
Figure Africa Rare Disease Drug Production Volume Share by Type in 2020 (Volume)
Figure Africa Rare Disease Drug Consumption Value Share by End-Use in 2020 (Million USD)
Figure Africa Rare Disease Drug Consumption Volume Share by End-Use in 2020 (Volume)
Figure Global Rare Disease Drug Revenue and Growth Rate Forecast 2020E-2025F (Million USD)
Figure Global Rare Disease Drug Production Volume and Growth Rate Forecast 2020E-2025F (Volume)
Figure Global Rare Disease Drug Revenue Share by Type in 2025 (Million USD)
Figure Global Rare Disease Drug Production Volume Share by Type in 2025 (Volume)
Figure Global Rare Disease Drug Consumption Value Share by End-Use in 2025 (Million USD)
Figure Global Rare Disease Drug Consumption Value Share by Region in 2025 (Million USD)
Figure Global Rare Disease Drug Consumption Volume Share by Region in 2025 (Volume)
Figure Europe Rare Disease Drug Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure Europe Rare Disease Drug Market Forecast and Growth Rate, 2020E-2025F (Million USD)
Figure America Rare Disease Drug Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure America Rare Disease Drug Market Forecast and Growth Rate, 2020E-2025F (Million USD)
Figure Asia Rare Disease Drug Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure AsiaRare Disease Drug Market Forecast and Growth Rate, 2020E-2025F (Million USD)
Figure Oceania Rare Disease Drug Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure Oceania Rare Disease Drug Market Forecast and Growth Rate, 2020E-2025F (Million USD)
Figure Africa Rare Disease Drug Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure Africa Rare Disease Drug Market Forecast and Growth Rate, 2020E-2025F (Million USD)
Figure Global Rare Disease Drug Revenue Share by Type in 2020 (Million USD)
Figure Global Rare Disease Drug Production Volume Share by Type in 2020 (Volume)
Figure Global Rare Disease Drug Consumption Value Share by End-Use in 2020 (Million USD)
Figure Global Rare Disease Drug Consumption Volume Share by End-Use in 2020 (Volume)
Figure Europe Rare Disease Drug Revenue Share by Type in 2020 (Million USD)
Figure Europe Rare Disease Drug Production Volume Share by Type in 2020 (Volume)
Figure Europe Rare Disease Drug Consumption Value Share by End-Use in 2020 (Million USD)
Figure Europe Rare Disease Drug Consumption Volume Share by End-Use in 2020 (Volume)
Figure America Rare Disease Drug Revenue Share by Type in 2020 (Million USD)
Figure America Rare Disease Drug Production Volume Share by Type in 2020 (Volume)
Figure America Rare Disease Drug Consumption Value Share by End-Use in 2020 (Million USD)
Figure America Rare Disease Drug Consumption Volume Share by End-Use in 2020 (Volume)
Figure Asia Rare Disease Drug Revenue Share by Type in 2020 (Million USD)
Figure Asia Rare Disease Drug Production Volume Share by Type in 2020 (Volume)
Figure Asia Rare Disease Drug Consumption Value Share by End-Use in 2020 (Million USD)
Figure Asia Rare Disease Drug Consumption Volume Share by End-Use in 2020 (Volume)
Figure Oceania Rare Disease Drug Revenue Share by Type in 2020 (Million USD)
Figure Oceania Rare Disease Drug Production Volume Share by Type in 2020 (Volume)
Figure Oceania Rare Disease Drug Consumption Value Share by End-Use in 2020 (Million USD)
Figure Oceania Rare Disease Drug Consumption Volume Share by End-Use in 2020 (Volume)
Figure Africa Rare Disease Drug Revenue Share by Type in 2020 (Million USD)
Figure Africa Rare Disease Drug Production Volume Share by Type in 2020 (Volume)
Figure Africa Rare Disease Drug Consumption Value Share by End-Use in 2020 (Million USD)
Figure Africa Rare Disease Drug Consumption Volume Share by End-Use in 2020 (Volume)
Figure Global Rare Disease Drug Revenue and Growth Rate Forecast 2020E-2025F (Million USD)
Figure Global Rare Disease Drug Production Volume and Growth Rate Forecast 2020E-2025F (Volume)
Figure Global Rare Disease Drug Revenue Share by Type in 2025 (Million USD)
Figure Global Rare Disease Drug Production Volume Share by Type in 2025 (Volume)
Figure Global Rare Disease Drug Consumption Value Share by End-Use in 2025 (Million USD)
Figure Global Rare Disease Drug Consumption Value Share by Region in 2025 (Million USD)
Figure Global Rare Disease Drug Consumption Volume Share by Region in 2025 (Volume)
